A research team at Florida State University's Institute of Molecular Biophysics and Department of Chemistry and Biochemistry ...
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...
No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...
Today's biomedical researchers are relentlessly searching for genes that drive disease, with the goal of creating therapies ...
mRNA CRISPR-based treatments offer enormous potential to transform patient care through personalised medicine The use of mRNA in therapeutics is growing ever wider following its success in Moderna’s ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
The loss of American chestnut trees, Castanea denatata, ranks as one of the most devastating botanical disasters in U.S. history. Before the introduction of chestnut blight in 1904, there were over 4 ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
Flu vaccines that take a page from the COVID-19 vaccine platform are making progress in clinical trials. In a phase 3 trial, Pfizer’s mRNA flu vaccine outperformed a traditional vaccine, researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback